West Pharmaceutical Services, Inc. Forecast, price target & analysts
Why the stock moved Beta
West Pharmaceutical Services, Inc. Target price 2025 - Analyst rating & recommendation
West Pharmaceutical Services, Inc. Classifications & Recommendation:
West Pharmaceutical Services, Inc. Price Target
| Target Price | $357.00 |
| Price | $269.08 |
| Potential |
32.67%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target West Pharmaceutical Services, Inc. 2026 .
The average West Pharmaceutical Services, Inc. target price is $357.00.
This is
32.67%
register free of charge
$393.75
46.33%
register free of charge
$287.85
6.98%
register free of charge
|
|
| A rating was issued by 21 analysts: 16 Analysts recommend West Pharmaceutical Services, Inc. to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the West Pharmaceutical Services, Inc. stock has an average upside potential 2026 of
32.67%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.89 | 3.10 |
| 1.92% | 6.97% | |
| EBITDA Margin | 25.75% | 24.23% |
| 9.84% | 5.89% | |
| Net Margin | 17.03% | 16.66% |
| 15.35% | 2.17% |
19 Analysts have issued a sales forecast West Pharmaceutical Services, Inc. 2025 . The average West Pharmaceutical Services, Inc. sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an West Pharmaceutical Services, Inc. EBITDA forecast 2025. The average West Pharmaceutical Services, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 West Pharmaceutical Services, Inc. Analysts have issued a net profit forecast 2025. The average West Pharmaceutical Services, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 6.69 | 7.17 |
| 15.10% | 7.17% | |
| P/E | 37.53 | |
| EV/Sales | 6.31 |
19 Analysts have issued a West Pharmaceutical Services, Inc. forecast for earnings per share. The average West Pharmaceutical Services, Inc. EPS is
This results in the following potential growth metrics and future valuations:
West Pharmaceutical Services, Inc....
Current West Pharmaceutical Services, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 02 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 27 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 24 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 02 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 27 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Oct 24 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 24 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 02 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
